| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $216.5M | — | +14.1% |
| Cost of Revenue | $88.6M | — | -0.2% |
| Gross Profit | $127.9M | — | +26.7% |
| R&D Expense | $41.9M | — | +10.6% |
| SG&A Expense | $32.2M | — | -0.4% |
| Operating Income | $27.7M | — | +1164.9% |
| Interest Expense | $636K | — | -11.4% |
| Pre-tax Income | $29.8M | — | +467.8% |
| Income Tax | $3.1M | — | +539.4% |
| Net Income | $26.6M | — | +460.5% |
| EPS (Basic) | $0.43 | — | +437.5% |
| EPS (Diluted) | $0.40 | — | +471.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $342.3M | -6.9% | -10.8% |
| Short-term Investments | $36.6M | -43.8% | -64.2% |
| Accounts Receivable | $74.2M | +43.5% | +18.5% |
| Current Assets | $524.6M | -5.7% | -15.2% |
| Total Assets | $1.25B | -2.3% | -7.7% |
| Current Liabilities | $562.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $56.3M | — | +29.4% |
| Capital Expenditures | $6.6M | — | +740.4% |
| Investing Cash Flow | $16.4M | — | +184.0% |
| Financing Cash Flow | -$97.2M | — | — |
| Free Cash Flow | $49.7M | — | +16.3% |
| +30.2% |
| Total Liabilities | $634.7M | +3.3% | -21.1% |
| Stockholders' Equity | $611.7M | -7.6% | +12.1% |